Business
Aytu BioScience Establishes COVID-19 IgG/IgM Rapid Test Product Inquiry Procedure for Healthcare Professionals and Institutions
Healthcare professionals, institutions, and other interested parties with questions about the Company's recently licensed COVID-19 IgG/IgM Rapid Test are
About this update from Aytu Biopharma, Inc.
[{"type":"text","content":"Healthcare professionals, institutions, and other interested parties with questions about the Company's recently licensed COVID-19 IgG/IgM Rapid Test are asked to send email inquiries to [email protected] ENGLEWOOD, CO / ACCESSWIRE / March 13, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today the establishment of a COVID-19 inquiry procedure to ensure the company adequately responds to inbound inquires from professionals and the public.In order to streamline and effectively capture the significant number of inbound inquiries related to the COVID-19 IgG/IgM Rapid Test, the company requests healthcare professionals, institutions, and other interested parties to send email inquiries to a COVID-19-dedicated email address.Inquiries should be directed via email to [email protected] Disbrow, Chief Executive Officer of Aytu BioScience, commented, \"Aytu BioScience is working to be as responsive as possible to the numerous inbound inquiries we're receiving relating to the COVID-19 Rapid Test. With the high volume of inbound calls and emails the Company has received, we want to ensure effective communication and timely response to these calls and emails.\"The COVID-19 IgG/IgM Rapid Test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma. This point-of-care test has been validated in a 113 patient clinical trial and has received CE marking. It is currently one of only a few tests used for coronavirus screening in China.About Aytu BioScience, Inc.Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The primary care portfolio includes (i) Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or \"Low T\"), (ii) ZolpiMist™, the only FDA-approved oral spray prescription sleep aid, and (iii) Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio incl...